LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
LeMaitre Vascular (Nasdaq:LMAT) will release first quarter 2026 financial results on Tuesday, May 5, 2026 after the market close and will host a conference call at 5:00 PM EDT the same day.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) will release first quarter 2026 financial results on Tuesday, May 5, 2026 after the market close and will host a conference call at 5:00 PM EDT the same day. Access is by registration for dial-in and PIN; an audio webcast and replay will be available at the company investor site.
Details
News Market Reaction – LMAT
On Apr 15, the first trading day after this news, LMAT closed 2.20% below the previous close.
Data tracked by StockTitan Argus for the Apr 15 session.
Key Figures
- Earnings release date
- May 5, 2026
- Q1 2026 financial results release after market close
- Conference call time
- 5:00 PM EDT
- Q1 2026 earnings conference call on May 5, 2026
- Announcement date
- April 14, 2026
- Date company disclosed Q1 2026 earnings release timing
Previous Earnings date Reports
-
Set timing and access details for Q4 2025 earnings release and call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
Contact: Gregory Manker Director, Business Development & Investor Relations LeMaitre Vascular, Inc. +1 781-362-1260 gmanker@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.